The development of a new anticancer drug with a novel structure and unique mechanism of action is an important event, especially when the drug plays a clear role in improving the outcome for cancer patients. No drug fits this description better than Taxol. However, during the early phases of its development, there was little interest in the drug, particularly in the medical community. The story of Taxol is long and fascinating, and includes many examples in which the drug could have been dropped, resulting in its antitumor activity never being available to patients. It was 21 years between the original landmark paper on the isolation and structural determination of Taxol and its approval in 1992 by the FDA for its use in the treatment of ovarian cancer
Nature as a remarkable chemist: A personal story of the discovery and development of Taxol
Wani, M., & Horwitz, SB. (2014). Nature as a remarkable chemist: A personal story of the discovery and development of Taxol. Anti-Cancer Drugs, 25(5), 482-487. https://doi.org/10.1097/CAD.0000000000000063
Abstract
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Recent Publications
OCCASIONAL PAPER
OCCASIONAL PAPER
Culturally informed community engagement
Article
Does the relationship between alcohol retail environment and alcohol outcomes vary by depressive symptoms? Findings from a US Survey of Black, Hispanic and White drinkers
Article